Senti Biosciences Holdings, Inc. (SNTI)

SNTI Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	8.94	16.42	48.28	35.93	57.62	56.03
Short-Term Investments	-	-	-	-	40.94	-
Cash & Short-Term Investments	8.94	16.42	48.28	35.93	98.56	56.03
Cash Growth	-73.57%	-65.99%	34.38%	-63.55%	75.90%	83.49%
Accounts Receivable	0.17	0.32	0.16	0.11	0.63	0.48
Other Receivables	0.59	1.27	1.65	18.71	-	-
Total Trade Receivables	0.77	1.6	1.81	18.82	0.63	0.48
Other Current Assets	5.09	5.26	8.88	17.57	3.39	3.68
Total Current Assets	14.79	23.27	58.96	71.2	102.58	60.19
Net Property, Plant & Equipment	19.92	24.4	35.24	41.61	69.78	33.08
Long-Term Investments	-	-	-	1.82	-	-
Other Long-Term Assets	3.53	3.55	3.64	3.74	8.43	3.43
Total Assets	38.24	51.22	97.84	119.48	180.79	96.7

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	1.05	2.94	1.45	1.25	1.37	5.19
Accrued Expenses	5.03	5.35	6.39	5.93	12.58	5.33
Current Portion of Leases	5.89	5.33	4.65	4.13	1.99	1.74
Unearned Revenue	0.03	0.04	-	-	0.8	1.66
Other Current Liabilities	2.27	0.3	0.66	1.37	1.32	0.63
Total Current Liabilities	14.27	13.97	13.15	12.67	18.05	14.54
Long-Term Leases	13.25	23.56	28.89	33.54	35.1	20.99
Other Long-Term Liabilities	8.16	8.1	5.05	6.36	0.37	0.8
Total Long-Term Liabilities	21.41	31.66	33.94	39.9	35.48	21.78
Total Liabilities	35.68	45.63	47.09	52.57	53.53	36.33

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0	0	0	0	0	-
Additional Paid-in Capital	365.36	364.16	322.78	311.26	300.54	3.62
Accumulated Other Comprehensive Income	-	-	-	-	0	-
Retained Earnings	-	-	-	-244.34	-173.29	-115.08
Total Common Shareholders' Equity	365.36	364.16	322.78	66.91	127.26	-111.46
Minority Interest	-	-	25.11	-	-	171.83
Shareholders' Equity	365.36	364.16	347.89	66.91	127.26	60.38
Total Liabilities & Equity	38.24	51.22	97.84	119.48	180.79	96.7

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	19.14	28.89	33.54	37.67	37.09	22.73
Net Cash (Debt)	-10.21	-12.47	14.74	-1.74	61.47	33.3
Net Cash Growth	-	-	-	-	84.58%	101.98%
Net Cash Per Share	-0.37	-0.56	3.21	-0.39	23.54	114.35
Book Value	365.36	364.16	322.78	66.91	127.26	-111.46
Book Value Per Share	13.21	16.20	70.23	15.08	48.74	-382.71
Tangible Book Value	365.36	364.16	322.78	66.91	127.26	-111.46
Tangible Book Value Per Share	13.21	16.20	70.23	15.08	48.74	-382.71

SEC Filings: 10-K · 10-Q

Data Source: Fiscal.ai Last updated: May 14, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 7, 2026

Data Sources Report a data error